Streetbeat News

Marketing

COIN

ETCUSD

HPE

MSTR

RIOT

Ethereum Classic surged 34% following the SEC's approval of Bitcoin ETFs, outperforming BTC and ETH. The global electric vehicle market saw a 31% increase in sales in 2023. Cathie Wood discussed her personal Bitcoin holdings and the SEC's decision. Jim Cramer commented on the potential market reaction to the ETF approval. Crypto-related stocks like Riot Blockchain, Coinbase, and MicroStrategy are trending due to the Bitcoin Spot ETF spotlight. In other news, Trump discussed his potential 2024 running mate, and a study predicted a $1 trillion boost to the US economy from generative AI. Samsung, Apple, Amazon, and HP Enterprise made headlines in tech, while the electric vehicle and consumer sectors also featured notable updates.

Portfolio Pulse from Akanksha Bakshi

January 11, 2024 | 2:17 pm

EDBL

Edible Garden AG Incorporated (NASDAQ:EDBL, EDBLW) announced that its new line of Pulp sustainable gourmet USDA Organic fermented sauces will be available at Target retail locations across the southeast. The launch includes a comprehensive marketing campaign and the distribution network now covers over 5,000 retail locations nationwide. The company expects the collaboration with Target to boost growth and visibility for the Pulp product line and the Edible Garden brand.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 2:13 pm

DLPN

Dolphin Entertainment, Inc. (NASDAQ:DLPN) has completed the formation of its 'Super Group' with the acquisition of Special Projects in Q4 2023. CEO Bill O'Dowd's letter to shareholders highlights the company's strategic initiatives, including accelerated synergies and cross-selling in core businesses, expansion into new verticals like skin care/cosmetics/beauty, and receiving equity stakes in marketed assets. Dolphin anticipates the premiere of the 'Blue Angels' documentary, the launch of a celebrity-partnered product, and the announcement of owned or co-owned live events. These ventures are expected to contribute to long-term growth and increased shareholder value without requiring cash investment from Dolphin.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 2:09 pm

BLIN

Bridgeline Digital, Inc.'s HawkSearch technology has been chosen by Nail Gun Depot to provide an AI-powered search bar for their website. The technology will enhance the customer shopping experience by displaying promotional content through keyword-triggered campaigns and categorizing products based on user ratings in relation to search terms.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 1:39 pm

MYNZ

Mainz Biomed N.V. (NASDAQ:MYNZ) is collaborating with TestDNA to present at the 10th Gdańsk Gastroenterology Symposium, focusing on the need for earlier detection of colorectal cancer (CRC). They will discuss non-invasive screening methods like ColoAlert, Mainz Biomed's at-home CRC screening kit. ColoAlert offers higher sensitivity and specificity than traditional fecal occult blood tests and is available in select EU countries. The US market represents a significant opportunity for ColoAlert, pending FDA approval from the ReconAAsense trial.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 1:05 pm

SEAT

Vivid Seats has become the secondary ticketing partner for the LA Kings and LA Galaxy through a partnership with AEG. This agreement allows fans to purchase tickets for all regular season home games via the Vivid Seats platform.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 1:04 pm

BDC

Belden Inc. has expanded its global presence by opening its fifth Customer Innovation Center (CIC) in Bengaluru, India. This move is part of the company's strategy to enhance customer engagement and drive innovation in the region.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 12:41 pm

KR

Kroger has partnered with MidOcean Partners to create MPearlRock, a strategic initiative aimed at introducing emerging consumer packaged goods (CPG) brands to new customers. This collaboration is designed to leverage Kroger's extensive retail presence and MidOcean's expertise in the CPG sector to support the growth and development of innovative brands.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 12:33 pm

HROW

Harrow Health, Inc. has announced the availability of Vevye, a patented cyclosporine ophthalmic solution for treating dry eye disease (DED) in the U.S. Vevye is unique for its 'water-free' semifulorinated alkane technology and is dispensed in a 10 microliter drop. It is the first cyclosporine-based product to treat both signs and symptoms of DED and comes with a 100% money-back guarantee.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 12:06 pm